Fatty Acid Synthase

Cat.No. Product Name Information Product Use Citations Product Validations
S9714 Denifanstat (TVB-2640) Denifanstat (TVB-2640) is an orally bioavailable, pharmacological fatty acid synthase (FAS/FASN) inhibitor with therapeutic potential in patients with NAFLD and nonalcoholic steatohepatitis.
bioRxiv, May 02 2025, nan
Endocrinology, March 13, 2023, bqad033
Frontiers in Oncology, July 11 2022, 899987
S9785 Fatostatin

Fatostatin (125B11), a diarylthiazole derivative, is a specific inhibitor of Sterol regulatory element binding proteins (SREBPs) activation. This compound binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. It suppresses growth and enhances apoptosis in cancer cells.

Annals of Translational Medicine, September 29, 2022, 958
Cancer Research, October 1, 2024, 3250-3266
Drug Design, Development and Therapy, August 26, 2020, 3535-3545
S1937 Isoniazid Isoniazid is a prodrug that blocks the action of fatty acid synthase by interacting with KatG, used for the prevention and treatment of tuberculosis.
Nature Metabolism, September 27, 2021, 1466-1475
Scientific Reports, October 4, 2021, 19634
Frontiers in Immunology, November 26, 2021, 712021
S8563 TVB-3664 TVB-3664 is a potent, selective, orally active and reversible inhibitor of fatty acid synthase (FASN) with IC50 of 0.018 μM and 0.012 μM for human and mouse cell palmitate synthesis, respectively.
Scientific Reports, November 11, 2021, 22085
Nature Communications, March 13, 2023, 1362
bioRxiv, July 5, 2023, nan
S4754 Betulin Betulin (BE, betulinol, betuline, betulinic alcohol), also known as betulinol, betuline, or betulinic alcohol, is a pentacyclic lupane-type triterpenoid naturally distributed in many plants and displays a broad spectrum of biological and pharmacological properties such as anticancer and chemopreventive activity. This compound (Trochol), is a sterol regulatory element-binding protein (SREBP) inhibitor with an IC50 of 14.5 μM in K562 cell line.
Journal of Pharmacology and Experimental Therapeutics, 30 July 2025, 103666
Frontiers in Oncology, 26 November 2021, 796152
Acta Biochim Biophys Sin -Shanghai), 2023, 55(9):1479-1486
S6666 FT113 FT113 is a potent inhibitor of fatty acid synthase (FAS/FASN) with ic50 of 213 nM.
Nature Metabolism, September 27, 2021, 1466-1475
Frontiers in Immunology, June 3, 2021, 618501
Oncotarget, 2025, 16:532-544
S8915 C75 trans C75 trans (trans-C75, (±)-C75) is a novel, potent synthetic inhibitor of fatty acid synthase (FAS/FASN) with IC50 of 35 μM and 50 μM in clonogenic assays and spheroid growth assay, respectively. C75 is used as a tool for studying fatty acid synthesis in metabolic disorders and cancer.
Biol Sex Differ, 2025, 16(1):9
Signal Transduct Target Ther, 2022, 7(1):46
Nat Metab, 2021, 10.1038/s42255-021-00479-4
E2667 IPI-9119 IPI-9119 is a potent, selective, and irreversible inhibitor of fatty acid synthase (FASN), which can inhibit the FASN thioesterase domain by promoting acylation of the catalytic serine with an IC50 of 0.3 nM.
Advanced Science, 2023, e2305902
S3300 Desoxyrhaponticin Desoxyrhaponticin (DC, DES), a stilbene glycoside from Rheum tanguticum Maxim. ex Balf. (rhubarb) which is a traditional Chinese nutritional food, is a fatty acid synthase (FAS/FASN) inhibitor. This compound is also a competitive inhibitor of glucose uptake with IC50 of 148.3 μM and 30.9 μM in rabbit intestinal membrane vesicles and in rat everted gut sleeves, respectively. It has apoptotic effect on human cancer cells.
Nat Metab, 2021, 10.1038/s42255-021-00479-4
Nature Metabolism, 2021, 1466-1475
E2900 Sodium palmitate Sodium palmitate (Palmitic acid sodium) is a common saturated fatty acid and produced during fatty acid synthesis. This compound enhances lipogenesis and cellular steatosis in various cell lines.
Cancer Lett, 2024, 597:217068